CG MedTech Statistics

Total Valuation

CG MedTech has a market cap or net worth of KRW 96.65 billion. The enterprise value is 66.38 billion.

Market Cap	96.65B
Enterprise Value	66.38B

Important Dates

The last earnings date was Friday, March 21, 2025.

Earnings Date	Mar 21, 2025
Ex-Dividend Date	n/a

Share Statistics

CG MedTech has 103.26 million shares outstanding. The number of shares has decreased by -23.05% in one year.

Current Share Class	n/a
Shares Outstanding	103.26M
Shares Change (YoY)	-23.05%
Shares Change (QoQ)	-78.56%
Owned by Insiders (%)	0.42%
Owned by Institutions (%)	n/a
Float	42.90M

Valuation Ratios

The trailing PE ratio is 1,619.16.

PE Ratio	1,619.16
Forward PE	n/a
PS Ratio	1.61
PB Ratio	0.28
P/TBV Ratio	1.17
P/FCF Ratio	131.19
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 108.50, with an EV/FCF ratio of 90.11.

EV / Earnings	1,112.11
EV / Sales	1.92
EV / EBITDA	108.50
EV / EBIT	n/a
EV / FCF	90.11

Financial Position

The company has a current ratio of 4.56, with a Debt / Equity ratio of 0.05.

Current Ratio	4.56
Quick Ratio	3.37
Debt / Equity	0.05
Debt / EBITDA	7.43
Debt / FCF	6.01
Interest Coverage	-5.90

Financial Efficiency

Return on equity (ROE) is -0.17% and return on invested capital (ROIC) is -0.88%.

Return on Equity (ROE)	-0.17%
Return on Assets (ROA)	-0.74%
Return on Invested Capital (ROIC)	-0.88%
Return on Capital Employed (ROCE)	-1.15%
Revenue Per Employee	314.75M
Profits Per Employee	542,654
Employee Count	110
Asset Turnover	0.37
Inventory Turnover	1.58

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -23.90% in the last 52 weeks. The beta is -0.43, so CG MedTech's price volatility has been lower than the market average.

Beta (5Y)	-0.43
52-Week Price Change	-23.90%
50-Day Moving Average	984.94
200-Day Moving Average	1,247.76
Relative Strength Index (RSI)	74.05
Average Volume (20 Days)	2,596,156

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CG MedTech had revenue of KRW 34.62 billion and earned 59.69 million in profits. Earnings per share was 1.00.

Revenue	34.62B
Gross Profit	15.79B
Operating Income	-1.10B
Pretax Income	12.86M
Net Income	59.69M
EBITDA	596.09M
EBIT	-1.10B
Earnings Per Share (EPS)	1.00

Full Income Statement

Balance Sheet

The company has 34.30 billion in cash and 4.43 billion in debt, giving a net cash position of 29.87 billion or 289.25 per share.

Cash & Cash Equivalents	34.30B
Total Debt	4.43B
Net Cash	29.87B
Net Cash Per Share	289.25
Equity (Book Value)	86.77B
Book Value Per Share	3,372.13
Working Capital	42.21B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.51 billion and capital expenditures -773.97 million, giving a free cash flow of 736.70 million.

Operating Cash Flow	1.51B
Capital Expenditures	-773.97M
Free Cash Flow	736.70M
FCF Per Share	7.13

Full Cash Flow Statement

Margins

Gross margin is 45.60%, with operating and profit margins of -3.17% and 0.17%.

Gross Margin	45.60%
Operating Margin	-3.17%
Pretax Margin	0.04%
Profit Margin	0.17%
EBITDA Margin	1.72%
EBIT Margin	-3.17%
FCF Margin	2.13%

Dividends & Yields

CG MedTech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	23.05%
Shareholder Yield	23.05%
Earnings Yield	0.06%
FCF Yield	0.76%

Stock Splits

The last stock split was on August 5, 2022. It was a forward split with a ratio of 5.

Last Split Date	Aug 5, 2022
Split Type	Forward
Split Ratio	5

Scores

CG MedTech has an Altman Z-Score of 3.84.

Altman Z-Score	3.84
Piotroski F-Score	n/a